BMPR2 and pulmonary arterial hypertension: In a recent publication, Theilmann and colleagues showed that BMP9 administration increased proliferation in blood outgrowth endothelial cells (BOECs) derived from PAH patients bearing BMPR2 mutations, as well as in BMPR2-silenced human pulmonary artery endothelial cells.